New choles­terol drug

Pharmacy Daily - - News -

NEWLY ap­proved for mar­ket­ing in Aus­tralia, Pralu­ent (alirocumab), a mon­o­clonal an­ti­body, is se­cond in a new class of medicines in­di­cated for a small group of pa­tients with high choles­terol who are dif­fi­cult to treat and have high car­diac risk.

PBAC will con­sider list­ing in Mar.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.